Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201307203436N3Phase 3Completed
Phase 3, randomised trial in opioid use disorder (OUD) comparing Dexmedetomidine arm with Ketamine arm (2 arms). Primary endpoint: Analgesic requirement. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201307203436N3.